⟵ Back to Search Results

BGB-290-102

Active, not recruiting

Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors

Beigene Study ID info

BGB-290-102

ClinicalTrials.gov ID info

NCT03333915

China Drug Trials ID info

CTR20160828

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents